Cibinqo (abrocitinib)

pCPA File Number: 21987
Negotiation Status:
Concluded with an LOI
Indication(s):
moderate to severe atopic dermatitis
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
SR0686
pCPA Engagement Letter Issued:
Negotiation Process Concluded: